Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Recombinant Salmon Calcitonin Dose Selection
NCT00620854Phase 2Completed
- Sponsor
- Tarsa Therapeutics, Inc.
- Start
- Feb 2008
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TBRIA in osteoporosis, sponsored by Tarsa Therapeutics, Inc.. Started Feb 2008; status: completed.
02
Drugs
TBRIA
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00620854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620854.